55
Participants
Start Date
December 6, 2018
Primary Completion Date
December 22, 2022
Study Completion Date
December 22, 2022
Palbociclib
Palbociclib is to be taken orally on days 5-18 (14 days) of each cycle (each cycle length is 21 days). The starting dose will be 125mg.
T-DM1
The recommended dose of T-DM1 is 3.6 mg/kg and is given as an intravenous infusion on Day 1 of every cycle (every 21 days).
Roswell Park Comprehensive Cancer center, Buffalo
Thomas Jefferson University Hospital, Philadelphia
Johns Hopkins Hospital, Baltimore
UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Cleveland Clinic, Cleveland
University of Wisconsin, Madison
Mosaic Life Care, Saint Joseph
JPS Health Network, Fort Worth
University of Colorado Denver, Aurora
University of Arizona Cancer Center, Tucson
University of New Mexico, Albuquerque
Cedar-Sinai, Beverly Hills
Oregon Health and Sciences University, Portland
Swedish Cancer Institute, Seattle
University of Washington, Seattle
Yale Cancer Center, New Haven
Collaborators (1)
Pfizer
INDUSTRY
University of Arizona
OTHER